These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 733841)

  • 1. 2-Deoxy-D-glucose-induced decrements in operant and reflex pain thresholds.
    Bodnar RJ; Kelly DD; Brutus M; Mansour A; Glusman M
    Pharmacol Biochem Behav; 1978 Oct; 9(4):543-9. PubMed ID: 733841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesia following intraventricular administration of 2-deoxy-D-glucose.
    Bodnar RJ; Merrigan KP; Wallace MM
    Pharmacol Biochem Behav; 1981 Apr; 14(4):579-81. PubMed ID: 7232479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Deoxy-D-glucose analgesia: influences of opiate and non-opiate factors.
    Bodnar RJ; Kelly DD; Glusman M
    Pharmacol Biochem Behav; 1979 Sep; 11(3):297-301. PubMed ID: 504309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of hypophysectomy upon analgesia induced by two glucoprivic stressors and morphine.
    Bodnar RJ; Kelly DD; Mansour A; Glusman M
    Pharmacol Biochem Behav; 1979 Sep; 11(3):303-8. PubMed ID: 504310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of analgesic and hyperphagic responses following 2-deoxy-D-glucose.
    Bodnar RJ; Kramer E; Simone DA; Kirchgessner AL; Scalisi J
    Int J Neurosci; 1983 Nov; 21(3-4):225-36. PubMed ID: 6584411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of stress-induced analgesia by apomorphine, but not by amphetamine.
    Bodnar RJ; Kelly DD; Brutus M; Greenman CB; Glusman M
    Pharmacol Biochem Behav; 1980 Aug; 13(2):171-5. PubMed ID: 7413686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related decrements in the analgesic and hyperphagic responses to 2-deoxy-D-glucose.
    Kramer E; Sperber ES; Bodnar RJ
    Physiol Behav; 1985 Dec; 35(6):929-34. PubMed ID: 3867904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeding induced by intracerebroventricular 2-deoxy-D-glucose in the rat.
    Miselis RR; Epstein AN
    Am J Physiol; 1975 Nov; 229(5):1438-47. PubMed ID: 1200165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of 2-deoxy-D-glucose on plasma glucose, free fatty acids and feeding during the light and dark cycle in rats.
    Larue-Achagiotis C; Le Magnen J
    Neurosci Biobehav Rev; 1980; 4 Suppl 1():33-7. PubMed ID: 6927711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyporesponsiveness to glucoprivation during postnatal period in the rat.
    Gil-Ad I; Udeschini G; Cocchi D; Müller EE
    Am J Physiol; 1975 Aug; 229(2):512-7. PubMed ID: 1163678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in responsiveness of the hypothalamic-pituitary-adrenocortical axis to 2-deoxy-D-glucose in developing rats.
    Widmaier EP
    Endocrinology; 1990 Jun; 126(6):3116-23. PubMed ID: 2161749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeding suppression induced by intra-ventricle III infusion of 1,5-anhydroglucitol.
    Tsutsui K; Sakata T; Oomura Y; Arase K; Fukushima M; Hinohara Y
    Physiol Behav; 1983 Oct; 31(4):493-502. PubMed ID: 6318243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracerebroventricular injections of 2-doexy-D-glucose, D-glucose and xylose on operant feeding in pigs.
    Parrott RF; Baldwin BA
    Physiol Behav; 1978 Sep; 21(3):329-31. PubMed ID: 740749
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed response to 2-deoxy-D-glucose in hypothalamic obese rats.
    King BM; Stamoutsos BA; Grossman SP
    Pharmacol Biochem Behav; 1978 Mar; 8(3):259-62. PubMed ID: 652834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Deoxy-D-glucose induced feeding: relation to diet palatability.
    Kanarek RB; Mayer J
    Pharmacol Biochem Behav; 1978 May; 8(5):615-7. PubMed ID: 674267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular 2-DG causes feeding in the absence of other signs of glucoprivation.
    Engeset RM; Ritter RC
    Brain Res; 1980 Nov; 202(1):229-33. PubMed ID: 7427740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased carbohydrate consumption by rats as a function of 2-deoxy-D-glucose administration.
    Kanarek RB; Marks-Kaufman R; Ruthazer R; Gualtieri L
    Pharmacol Biochem Behav; 1983 Jan; 18(1):47-50. PubMed ID: 6828537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic 2-deoxy-D-glucose treatment: adaptation of its analgesic, but not hyperphagic properties.
    Bodnar RJ; Kelly DD; Brutus M; Glusman M
    Pharmacol Biochem Behav; 1978 Dec; 9(6):763-8. PubMed ID: 746052
    [No Abstract]   [Full Text] [Related]  

  • 19. Feeding elicited by 2-deoxyglucose occurs in the absence of reduced glucose oxidation.
    Nonavinakere VK; Ritter RC
    Appetite; 1983 Sep; 4(3):177-85. PubMed ID: 6421229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-deoxy-D-glucose-induced hyperglycemia: role for direct sympathetic nervous system activation of liver glucose output.
    Pascoe WS; Smythe GA; Storlien LH
    Brain Res; 1989 Dec; 505(1):23-8. PubMed ID: 2611676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.